MCAS Treatment Failure FAQ
Short, precise answers when stabilizers stop working — and a clear line about where education ends and clinical care begins.
What this FAQ is for
Patients hit treatment failure with predictable questions, and most of those questions deserve a precise, one-paragraph answer. This page is that. It is not a protocol. It does not replace your allergist, your immunologist, your gastroenterologist, or your primary care clinician. It is orientation — enough mechanism to ask better questions inside the clinical relationship you already have.
What it is not for
- Self-directed medication changes of any kind.
- Diagnosing yourself or anyone else with MCAS or any subtype.
- Managing acute reactions. Acute airway or circulatory symptoms are an emergency.
- Replacing the workup that confirms or excludes clonal mast cell disease.
The frame in one paragraph
Mast cells fire because something is telling them to. In refractory cases, that something is often persistent and internal — translocated endotoxin, dysbiotic metabolites, post-viral antigen, or an immune system that has depleted NAD+ and lost the capacity to stand the cell back down. Stabilizers protect the patient while the upstream input is addressed. They are not designed to make a persistent stimulus go away.
Where to go from here
The longer mechanistic account lives on the MCAS pillar page. The four-pattern stratification is laid out in the four mechanistically distinct patterns. The framework these pages share is the Host Capacity Model. Bring any of it to the clinician managing your case; do not act on any of it alone.